Global Biosensors in Medical Diagnostics Industry

  • February 2012
  • -
  • Global Industry Analysts

This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in US$ Million by the following Product Segments: Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 89 players including major companies developing Biosensor-Based Devices such as Abbott Point of Care, Inc., Siemens Healthcare Diagnostics Inc., Animas Corporation, Lifescan, Inc., Medtronic Diabetes, Hoffman La Roche, Leading Developers of Biosensor Technology: AgaMatrix Inc., Cranfield Health, LifeSensors INC., M-Biotech, and Nova Biomedical Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table Of Contents





I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-3
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Medical Biosensors I-4
Glucose Biosensors I-4
Other Medical Biosensors I-4
Environmental Biosensors I-4
Other Biosensors I-4


II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW AND ANALYSIS II-1
Recession Leaves Biosensors Market Unruffled II-1
Increasing Medical Applications for Biosensors II-1
Swift Growth of Biosensors Demand in Medical Diagnostics II-1
Key Facts II-1
Reasons for Slow Commercialization II-2
Regulations Encumber Biosensors Market Growth II-2
Impediments to Commercialization II-3
Medical Biosensors: A Promising Area II-3
Painless Technologies Spark Evolution in Glucose Monitoring
Segment II-4
Biosensors Primarily Used in Blood Gas/Electrolyte Analyzers,
Glucose Meters and Metabolite Analyzers II-4
Cutting-Edge Design - Order of the Day II-4
Use of Medical Biosensors in Artificial Organs II-4
Growing Demand and RandD Activities Drive the Biosensors Market II-5
The Road Ahead II-5

2. A RETROSPECTIVE II-6

3. COMPETITIVE SCENARIO II-7
Table 1: Leading Players in Glucose Biosensor Market (2008):
Market Share Breakdown based on Value Sales for Roche
Diagnostics, Lifescan, Abbott, Bayer, Medtronic, and Others
(includes corresponding Graph/Chart) II-7
Intensity of Competition II-7

4. PRODUCT OVERVIEW II-9
About Biosensors II-9
Types of Biosensors II-9
Components of Biosensors II-10
Types of Biosensors II-10
Glucose Sensor II-10
Medical Telesensors II-11
Detecting Cancer and Health Abnormalities II-11
Lactate Sensor II-11
Alcohol Sensor II-12
Biochemical Oxygen Demand Sensor (BOD) II-12
Bioreporters II-12
Miniaturized Devices II-12
Components of Biosensors II-12
Receptor II-12
Transducer II-12
Separator II-13
Biological Components II-13
Attributes of a Good Biosensor II-13
Classes of Biosensors II-14
Potentiometric II-14
Amperometric II-14
Optical Biosensors II-14
Other Physicochemical Biosensors II-15
Methods to Produce Optical Biosensors II-15
Simple Fiber Optic Biosensors II-15
Evanescent Wave System II-15
Surface Plasmon Resonance (SPR) II-15

5. APPLICATION AREAS II-16
A. Medical Applications II-16
Glucose Meters II-16
The Diabetes Monitoring Market II-16
Table 2: Worldwide Prevalence of Diabetes Mellitus by
Region: 2010 and 2030 (includes corresponding Graph/Chart) II-17
Categorization II-18
Biosensors in Home Glucose Monitors II-18
PBGM Devices: Based on Photometric or Biosensor Technology II-18
Product Innovations Rule the Roost II-19
Non-Invasive Products II-19
Blood Gas Market II-20
Sensors Facilitate Analysis of Blood II-20
Market for DNA Biosensors and Genechips in Nascent Stage II-21
B. Environmental Biosensors II-21
C. Industrial Applications II-22
Summarization of Available Biosensors and Technological
Applications II-23
D. Other Application Areas II-23
Biological Warfare- An Increasingly Important Area for
Biosensors II-23
Fingerprinting - A Much Needed Advantage? II-23
Biosensors: Speeding Pathogen Detection... II-23

6. PRODUCT LAUNCHES/INNOVATIONS II-25
ForteBio Introduces Dip and ReadTM Protein G biosensor for
Octet Instruments II-25
Universal Biosensors to Unveil OneTouch Verio Blood Glucose
Tester for Diabetic Patients II-25
STMicroelectronics to Introduce Smallest Biosensors II-25
WaveSense Europe Unveils New Jazzâ„¢ Blood Glucose Meter in UK II-26
Mexico Inventors Develop Integrated Optical Biosensor System II-26
New Biosensor Detects Avian Influenza Virus II-26
US Scientists to Develop Nano-based Biosensor II-26
Japanese Inventors Develop New Biosensor II-26
US Scientists Develops New Biosensor II-27
NeoSensors Re-Introduces Biosensor Product Range II-27
Siemens Medical Releases Rapidlab Version 2.0 Software II-27
Innovative Biosensors Unveils BioFlash Biological Detector II-27
Medtronic Introduces Guardian® Real-Time System for Diabetes
Management II-27
Nova Biomedical Introduces Nova Maxâ„¢ Blood Glucose Monitor II-28
ARKRAY Introduces PocketChem EZ Blood Glucose Monitoring Device II-28
Medtronic Unveils Continuous Glucose Monitoring System II-28
Abbott Introduces FreeStyle Lite II-28
SPO Medical Launches Two Oximetry Devices II-29
ForteBio Launches New Biosensors for Research and Development II-29
Axela Biosensors Unveils dotLabâ„¢ System II-29
California Inventor Develops Anti Inflammatory Biosensor II-30
Japanese Inventors Develop Measuring System for Biosensor II-30
Biophage Develops New Biosensor II-30
AMBRI Develops New Influenza Biosensor II-30
LifeScan Unveils OneTouch® UltraMini™ Blood Glucose Monitoring
System II-30
Akubio Introduces RAP•d 4 Biomolecular Interactions Analysis
System II-30
Bio-Rad Launches ProteOn XPR36 Protein Interaction Array System II-31
Exmovere Introduces Bluetooth-Enabled Biosensor Wristwatch II-31
SPO Medical Unveils Compact Oximetry System, PulseOx 7500â„¢ II-32
Panasonic Introduces Multi-Task Biosensor for Disease Detection II-32
Medtronic Launches Glucose Monitoring System in India II-32
ForteBio Introduces New Biosensors for Octet System II-32

7. RECENT INDUSTRY ACTIVITY II-34
ActiveCare Collaborates with Vista Therapeutics to Develop
Nano-Biosensors II-34
Innovative Biosensors Partners with ProGenTech II-34
Rheonix Completes IBI Acquisition II-34
Abbott Acquires Ibis Biosciences II-35
China Medical and Molecular Diagnostics Technologies Ink
Agreement II-35
Medtronic Receives FDA Clearance on OneTouch® U ltralink™ II-36
Medtronic Bags FDA Approval on CGMS® iPro™ II-36
T+ Medical Partners LifeScan for Diabetes Management II-36
Aerotel Medical Systems Takes Over Tadiran LifeCare’s Business
Operations II-37
Siemens Medical Completes Acquisition of Bayer’s Diagnostic
Division II-37
Siemens Signs Merger Agreement with Dade Behring II-37
Abbott Divests Two Diagnostics Division to GE II-38
Axela and BioCheck Inks License and Supply Agreement II-38
FDA Grants Waiver for Abbott’s i-STAT CHEM8+ II-38
Aventir Receives FDA Approval for GlucosePilotâ„¢ II-39
Inscent to Develop New Biosensor to Save Public Health II-39
Wellion® Linus Receives TNO Approval II-39
Virogenomics Receives Grant of US$1.9M to Develop BioSensor
Technology II-39
Acacia Acquires Rights to Patent for Pointing Device Technology II-39
NanoSensors Grants Sub-Contract for Prototype Production of
Biosensor II-39
Axela and Toronto University to Develop Patient Bedside
Testing Devices II-40
Attana and Isogen Ink a Distribution Agreement II-40
Biosense Webster Expands Alliance with Stereotaxis II-40
Medtronic Enters into Exclusive Distribution Agreement with
LifeScan II-40
WaveSense to Launch European Subsidiary, WaveSense Europe II-41

8. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-42
MedMira Acquires SensorChem II-42
Siemens Acquires Diagnostic Products Corporation II-42
Farfield Group Acquires Biosensor Operations of Thermo Electron II-42
Kimberly-Clark Acquires Stake in Axela Biosensors II-43
Bionas and Primacyt Co-operates to Develop Cell-Based Assay II-43
Biosensors Japan Co. to Sell Stents in Japan II-43
Isis Receives Copyright for Pathogen Identification Methodology II-43
Micronics Issues Patent License to Cleveland II-44
Medtronic Receives US FDA Approval on New CGM System II-44
AgaMatrix Bags FDA Approval to Market Wave 1â„¢ II-44
Bruker Daltonics Enters into Strategic Alliance with Isis
Pharmaceuticals II-44
NeuroMetrix Inks Manufacturing Agreement with Parlex USA II-45
Synthetic Blood International Enters into Strategic Alliance
With UTEK II-45
EPSRC Enters Joint Research Agreement with Philips II-45
Biophage Pharma Enters Agreement with Biosensor Systems II-45
Axis Participates in Biosensor Platform Development Project II-46
US Genomics Bags Biosensor Contract from DHS II-46
Bio-Nano Sensium Files Patent Application for Wireless Biosensors II-46
SPO Medical Completes Reverse Acquisition of United Diagnostic II-46
Biophage Pharma Develops New Technology to Detect Bacteria II-46
Cygnus Turns to Liquidation II-47
TGC Research Acquires Certain Assets of Diametrics II-47
Abbott Acquires I-Stat II-47
Diametrics Restructures II-47
Seahawk Contracts with In-Q-Tel II-47
Pinnacle Signs an Agreement with Primetech II-48
RoboDesign Enters into an Agreement with Isis II-48
Theron Enters into a Licensing Agreement II-48
Innovative Biosensors Enters Licensing Agreement with MIT II-48
Biosensors International and X-Cell Medical Mutually Agree to
Form a New Company II-48
Biosensors International Private Ltd. Divests Stent System to
Guidant Corporation II-49
Medtronic Acquires MiniMed Inc. and Medical Research Group Inc. II-49
Virtek Vision Acquires FONA Diagnostics II-49
Dow Corning Strategically Alliances with Genencor II-49
Synthetic Blood International Obtains Patent II-50
Prolinx Forges an Agreement with Texas Instruments II-50
Kumetrix Bags SBIR Contract from NIDDK II-51
Standard MEMS Forms BioMEMS Technology Group II-51

9. TECHNOLOGY DEVELOPMENTS IN THE RECENT PAST - A PERSPECTIVE BUILDER II-52
Holograms - The Next Generation Biosensors II-52
Smart Bandages - A New Way of Wound Care II-52
PulseTracer Unveils PT100 Biosensor II-52
Molecular Biology- Increasingly Used in the Biosensor Business II-52
Micro-System Platforms for Biosensor Applications II-53
Microelectromechanical Systems- Creating New Horizons II-53
Biochips: Increasingly Being Used in Point-Of-Care Devices II-54
Implantable Biosensors: A Possibility in the Near Future II-54
Biosensors to Carry Out Medical-Checkups at Home II-54
Immunosensors to Enhance Current Immunoassay Techniques II-55
Microfluidic Glucose Sensor II-55
Biosensors in Mycotoxin Detection II-55
Some Major Technological Developments in the Recent Years II-55
Animas into Development of Implantable Sensors for Blood Glucose II-55
Cytoplex' Develops Biosensor II-56
Immunosensor Ricin Detector II-56
Biosensor to Identify Viruses Electronically II-56
Electrochemical Array Biosensor Technology II-56
Polymer-Coated Microheaters Enters Market II-56
Technology Archive II-57
UCSD Instrumental Develops Polymer-based Nanoscale Biosensors II-57
Applied Digital Solutions Launches VeriChipâ„¢ II-57
Applied Digital Solutions Inc. Incorporates Biosensors
Technology in New Device II-58
University of Rhode Island Develops Biosensor to Detect
Pathological Bacteria in Foods II-58
Cellomics Commences Development of Biowarfare Detection II-58
Optic Interferometic Sensor for Detecting Biological Hazards
and Attacks II-58
Digital Signal Processing Technology (DSP) in Biosensors II-59
The World’s Smallest Biosensors II-59
MiniMed Gains FDA Approval for Its Subcutaneous Glucose Sensor II-60
The Nanomachine: The World’s Smallest Machine II-60
Knoxville Cancer Survival Center Develops Laser-based Sensor II-60
Genetic Engineering Creates Biosensors to Clean Environment II-60
New Horizons Develops Immunoassay Tests II-61
John Hopkins University Develops New Alfa-Toxin Fab II-61
Texas Instruments Develops a New Surface Plasmon Resonance
Sensor II-62
A New Biosensor to Confirm Pregnancy II-62
Gold Biosensor to Detect Carcinogens II-62
Drug Detecting Biosensor II-63
Functional Genomics Technology Uses Biosensors II-63

10. FOCUS ON SELECT PLAYERS II-64
Companies Developing Biosensor-Based Devices II-64
Abbott Point of Care, Inc. (USA) II-64
Siemens Healthcare Diagnostics Inc (USA) II-64
Animas Corporation (USA) II-64
Lifescan, Inc. (USA) II-64
Medtronic Diabetes (USA) II-65
Hoffman La Roche (Switzerland) II-65
Leading Developers of Biosensor Technology II-65
AgaMatrix Inc. (USA) II-65
Cranfield Health (UK) II-65
LifeSensors INC. (USA) II-66
M-Biotech (USA) II-66
Nova Biomedical Corp. (USA) II-66

11. GLOBAL MARKET PERSPECTIVE II-67
Table 3: World Recent Past, Current and Future Market Analysis
for Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-67

Table 4: World Historic Review for Biosensors by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) II-68

Table 5: World 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) II-69

Table 6: World Recent Past, Current and Future Market Analysis
for Medical Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017(includes corresponding
Graph/Chart) II-70

Table 7: World Historic Review for Medical Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-71

Table 8: World 15-Year Perspective for Medical Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) II-72

Table 9: World Recent Past, Current and Future Market Analysis
for Medical Biosensors by Product Segments- Glucose Biosensors
and Other Medical Biosensors Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-73

Table 10: World Historic Review for Medical Biosensors by
Product Segment - Glucose Biosensors and Other Medical
Biosensors Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-74

Table 11: World 15-Year Perspective for Medical Biosensors by
Product Segment- Percentage Breakdown of Value Sales for
Glucose Biosensors and Other Medical Biosensors Markets for
Years 2003, 2011 and 2017 II-75

Table 12: World Recent Past, Current and Future Market Analysis
for Glucose Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-76

Table 13: World Historic Review for Glucose Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-77

Table 14: World 15-Year Perspective for Glucose Biosensor by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) II-78

Table 15: World Recent Past, Current and Future Market Analysis
for Other Medical Biosensors by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-79

Table 16: World Historic Review for Other Medical Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-80

Table 17: World 15-Year Perspective for Other Medical
Biosensor by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Rest of World Markets for Years 2003, 2011 and
2017(includes corresponding Graph/Chart) II-81

Table 18: World Recent Past, Current and Future Market Analysis
for Environmental Biosensors by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-82

Table 19: World Historic Review for Environmental Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-83

Table 20: World 15-Year Perspective for Environmental
Biosensor by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Rest of World Markets for Years 2003, 2011 and 2017.
(Includes corresponding Graph/Chart) II-84

Table 21: World Recent Past, Current and Future Market Analysis
for Other Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-85

Table 22: World Historic Review for Other Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-86

Table 23: World 15-Year Perspective for Other Biosensor by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) II-87


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
The US Diabetes Monitoring Market III-1
B.Market Analytics III-2
Table 24: The US Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-2

Table 25: The US Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-3

Table 26: The US 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-4

2. CANADA III-5
A.Market Analysis III-5
Biosensor Researches in Canada III-5
Microfluidic Systems III-5
Biosensor Institutions III-5
B.Market Analytics III-6
Table 27: Canadian Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-6

Table 28: Canadian Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-7

Table 29: Canadian 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-8

3. JAPAN III-9
Market Analysis III-9
Table 30: Japanese Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-10

Table 31: Japanese Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-11

Table 32: Japanese 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-12

4. EUROPE III-13
A.Market Analysis III-13
Market Trends and Issues III-13
Environmental Monitoring Diffusing in the European Countries III-13
B.Market Analytics III-14
Table 33: European Recent Past, Current and Future Market
Analysis for Biosensors by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) III-14

Table 34: European Historic Review for Biosensors by
Geographic Region - France, Germany, Italy, UK, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-15

Table 35: European 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for
Years 2003, 2011 and 2017 (includes corresponding Graph/Chart) III-16

Table 36: European Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-17

Table 37: European Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-18

Table 38: European 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-19

4a. FRANCE III-20
Market Analytics III-20
Table 39: French Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-20

Table 40: French Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-21

Table 41: French 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-22

4b. GERMANY III-23
Market Analytics III-23
Table 42: German Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-23

Table 43: German Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-24

Table 44: German 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-25

4c. ITALY III-26
Market Analytics III-26
Table 45: Italian Recent Past, Current and Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-26

Table 46: Italian Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-27

Table 47: Italian 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-28

4d. THE UNITED KINGDOM III-29
A.Market Analysis III-29
Outlook of Industrial Biosensors III-29
B.Market Analytics III-30
Table 48: UK Recent Past, Current and Future Market Analysis
for Biosensors by Product Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-30

Table 49: UK Historic Review for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-31

Table 50: UK 15-Year Perspective for Biosensors by Product
Segment - Percentage Breakdown of Value Sales for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-32

4e. REST OF EUROPE III-33
Market Analytics III-33
Table 51: Rest of Europe Market for Biosensors - Recent
Past, Current and Future Analysis by Product Segment for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-33

Table 52: Rest of Europe Historic Review for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) III-34

Table 53: Rest of Europe 15-Year Perspective for Biosensors
by Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-35

5. ASIA-PACIFIC III-36
Market Analytics III-36
Table 54: Asia-Pacific Market for Biosensors - Recent Past,
Current and Future Analysis by Product Segment for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-36

Table 55: Asia-Pacific Historic Review for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) III-37

Table 56: Asia-Pacific 15-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-38

6. REST OF WORLD III-39
Market Analytics III-39
Table 57: Rest of World Market for Biosensors - Recent Past,
Current and Future Analysis by Product Segment for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-39

Table 58: Rest of World Historic Review for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) III-40

Table 59: Rest of World 15-Year Perspective for Biosensors
by Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-41


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 89 (including Divisions/Subsidiaries - 102)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 64
Canada 5
Japan 4
Europe 24
Germany 6
The United Kingdom 11
Rest of Europe 7
Asia-Pacific (Excluding Japan) 4
Middle-East 1
------------------------------------------

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.